- Phase 2 since 5 Apr 2026: Beijing Biotech’s first study of it at that phase, by the day it was submitted to ClinicalTrials.gov.
- Next primary completion: 18 Feb 2027, the registry's estimate, of NCT07480941 (phase 1) — when its main measure’s data collection ends, not when results are announced.study pageClinicalTrials.gov ↗
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies GlaxoSmithKline leads of it in the last 24 months also tests belantamab mafodotin.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Aurobindo Pharma leads of it also tests belinostat, pralatrexate, Vincristine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Pfizer leads of it also tests palbociclib, Irinotecan, Topotecan.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Genmab leads of it also tests Vincristine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 2 studies Eli Lilly and Company leads of it also tests Ramucirumab, Gemcitabine, abemaciclib.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Evopoint Biosciences Inc. leads of it also tests XNW5004.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies SynerGene Therapeutics, Inc. leads of it also tests Topotecan.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 3 studies Johnson & Johnson leads of it also tests Bortezomib, Thalidomide, daratumumab.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Zydus Lifesciences Limited leads of it also tests eflapegrastim.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Cartesian Therapeutics leads of it also tests Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 2 studies CSPC Pharmaceutical Group Limited leads of it also tests Vincristine, Liposomal Mitoxantrone Hydrochloride.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies ADC Therapeutics S.A. leads of it also tests loncastuximab tesirine, Vincristine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Marker Therapeutics, Inc. leads of it also tests Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 8 studies Hebei Senlang Biotechnology Inc., Ltd. leads of it also tests Auto CAR-T, CD19 CAR-T, Anti-CD22 CAR-expressing T Lymphocytes.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Aduro Biotech, Inc. leads of it also tests CRS-207.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Eisai Co., Ltd. leads of it also tests denileukin diftitox, Vincristine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Swedish Orphan Biovitrum leads of it also tests pixantrone, Vincristine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Heat Biologics leads of it also tests viagenpumatucel-l.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Alden Cancer Therapy II leads of it also tests Dendritic cell based cryoimmunotherapy.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Nohla Therapeutics, Inc. leads of it also tests dilanubicel.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Eske Corporation S.A.C leads of it also tests glycated chitosan.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies UbiVac leads of it also tests DRibble Vaccine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Shanghai GeneChem Co., Ltd. leads of it also tests Anti-CD19 CAR T Cells Preparation.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Otsuka Holdings Co., Ltd. leads of it also tests Busulfan, Etoposide.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Genta Incorporated leads of it also tests oblimersen.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Swami Rama Cancer Hospital and Research Institute leads of it also tests Etoposide.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Cell Genesys leads of it also tests Autologous GM-CSF-secreting Lethally Irradiated Lung Cancer Vaccine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 56 companies; each of the 1 studies Teva Pharmaceutical Industries, Ltd. leads of it also tests Vincristine.
|